EUCTR2005-001058-26-IT进行中（未招募）不适用
VICRIVIROC SCH 417690 in combination treatment with optimized ART regimen in Experienced subjects VICTOR E2 .
SCHERING-PLOUGH0 个研究点目标入组 500 人开始时间: 2007年1月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
VICRIVIROC SCH 417690 in combination treatment with optimized ART regimen in experienced subjects VICTOR-E1 .EUCTR2005-001057-21-ITSCHERING-PLOUGH500
进行中（未招募）
1 期
Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E1) - VICTOR-E1HIV infection (R5-tropism only) with previous therapyLevel: LLTClassification code 10200172EUCTR2005-001057-21-PTSchering-Plough Research Institute
进行中（未招募）
1 期
Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E1) - VICTOR-E1HIV infection (R5-tropism only) with previous therapyLevel: LLTClassification code 10200172EUCTR2005-001057-21-GBSchering-Plough Research Institute
进行中（未招募）
1 期
Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E2) - VICTOR-E2HIV infection (mixed X4/R5 torpism) with previous therapyLevel: LLT Classification code 10020172EUCTR2005-001058-26-PTSchering-Plough Research Institute500
进行中（未招募）
不适用
Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E2) - VICTOR-E2HIV infection (mixed X4/R5 torpism) with previous therapyLevel: LLTClassification code 10020172EUCTR2005-001058-26-DESchering-Plough Research Institute500